| Family planning at 70% | Family planning at 75% | Family planning at 80% | |||
---|---|---|---|---|---|---|
 | Number of lives saved | Incremental costs (US$) | Number of lives saved | Incremental costs (US$) | Number of lives saved | Incremental costs (US$) |
Interventions for stillbirths | Â | Â | Â | Â | Â | Â |
Syphilis detection and treatment | 160 | 106 550 | 120 | −2 544 770 | 90 | −4 794 400 |
Hypertensive disease case management | 610 | 35 040 | 470 | 21 240 | 360 | 9 520 |
Diabetes case management | 180 | 8 194 520 | 140 | 7 932 270 | 110 | 7 694 400 |
MgSO4 Management of pre-eclampsia | 520 | 5 492 600 | 410 | −917 110 | 310 | −6 355 730 |
Fetal growth restriction detection and management | 690 | 2 876 410 | 530 | 2 784 350 | 400 | 2 700 860 |
Labor and delivery management | 4990 | 19 447 320 | 3 870 | −41 901 940 | 2 920 | −93 956 580 |
Induction of labor for pregnancies lasting 41+ weeks | 390 | 2 436 610 | 300 | 1 856 720 | 230 | 1 364 690 |
Interventions for maternal and newborn health | Â | Â | Â | Â | Â | Â |
Early detection and treatment of HIV | 610 | 10 930 280 | 470 | 2 462 090 | 360 | −4 705 650 |
Tetanus toxoid immunization | 52 | 614 240 | 40 | −193 090 | 30 | −878 110 |
Antibiotics for PPROM | 490 | 769 780 | 380 | 542 300 | 280 | 349 290 |
Antenatal corticosteroids | 2030 | 4 527 270 | 1 580 | 3 269 430 | 1 190 | 2 202 160 |
Active management of the third stage of labor | 80 | 1 547 670 | 70 | 25 240 | 50 | −1 266 540 |
Neonatal resuscitation | 760 | 81 670 | 590 | 51 850 | 440 | 26 330 |
Total | 11 562 | 57 059 960 | 8 970 | −26 611 420 | 6 770 | −97 609 760 |